Linked Life Data

20581169

Source:http://linkedlifedata.com/resource/pubmed/id/20581169

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2010-11-2
pubmed:databankReference
pubmed:abstractText
Pulmonary arterial hypertension (PAH) is a progressive condition with a poor prognosis. Platelet-derived growth factor receptor (PDGFR) signaling plays an important role in its pathobiology.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/20581169-10508235, http://linkedlifedata.com/resource/pubmed/commentcorrection/20581169-11907289, http://linkedlifedata.com/resource/pubmed/commentcorrection/20581169-12091180, http://linkedlifedata.com/resource/pubmed/commentcorrection/20581169-12533438, http://linkedlifedata.com/resource/pubmed/commentcorrection/20581169-12588707, http://linkedlifedata.com/resource/pubmed/commentcorrection/20581169-16192491, http://linkedlifedata.com/resource/pubmed/commentcorrection/20581169-16200212, http://linkedlifedata.com/resource/pubmed/commentcorrection/20581169-16291984, http://linkedlifedata.com/resource/pubmed/commentcorrection/20581169-16862153, http://linkedlifedata.com/resource/pubmed/commentcorrection/20581169-16946127, http://linkedlifedata.com/resource/pubmed/commentcorrection/20581169-17151364, http://linkedlifedata.com/resource/pubmed/commentcorrection/20581169-17540207, http://linkedlifedata.com/resource/pubmed/commentcorrection/20581169-17853901, http://linkedlifedata.com/resource/pubmed/commentcorrection/20581169-18083403, http://linkedlifedata.com/resource/pubmed/commentcorrection/20581169-18165615, http://linkedlifedata.com/resource/pubmed/commentcorrection/20581169-1863023, http://linkedlifedata.com/resource/pubmed/commentcorrection/20581169-18779455, http://linkedlifedata.com/resource/pubmed/commentcorrection/20581169-18936500, http://linkedlifedata.com/resource/pubmed/commentcorrection/20581169-18938156, http://linkedlifedata.com/resource/pubmed/commentcorrection/20581169-19155250, http://linkedlifedata.com/resource/pubmed/commentcorrection/20581169-19470885, http://linkedlifedata.com/resource/pubmed/commentcorrection/20581169-8532025, http://linkedlifedata.com/resource/pubmed/commentcorrection/20581169-9596101
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1535-4970
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
182
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1171-7
pubmed:dateRevised
2011-7-28
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy.
pubmed:affiliation
Pulmonary Hypertension Division, Medical Clinic II/V, University Hospital Giessen und Marburg GmbH, Giessen, Germany. ardeschir.ghofrani@innere.med.uni-giessen.de
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Clinical Trial, Phase II